WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Contineum Therapeutics earnings were -$57.6M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest CTNM earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$15.2M, up 4.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CTNM reported annual earnings of -$60.0M, with 41.9% growth. The next CTNM earnings date is Oct 29, 2026.

CTNM earnings history

Current Revenue
$0.0
Current Earnings
-$57.6M
Current Profit Margin
0%

CTNM Return on Equity

Current Company
-24.7%
Current Industry
-10.8%
Current Market
30.9%
CTNM's Return on Equity (-24.7%)... subscribe to Premium to read more.
High Return on Equity Performance

CTNM Return on Assets

Current Company
-23.5%
Current Industry
-10.7%
CTNM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CTNM announces earnings.

CTNM Return on Capital Employed

Current Company
-23.6%
Current Industry
-7.4%

CTNM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTNM-$55.41M-$57.56MN/A-$1.73
ENTX-$17.04M-$17.03MN/A-$0.35
PBYI$45.17M$26.72M+68.59%$0.54
RGNX-$139.12M-$196.43MN/A-$3.79
SLN-$59.47M-$59.95MN/A-$1.32
View Top Biotech Stocks

CTNM earnings dates

Next earnings date
Oct 29, 2026

Contineum Therapeutics Earnings Reports & History FAQ

What were Contineum Therapeutics's earnings last quarter?

On CTNM's earnings call on Aug 4, 2026, Contineum Therapeutics (NASDAQ: CTNM) reported Q2 2026 earnings per share (EPS) of -$0.40, up 35.48% year over year. Total CTNM earnings for the quarter were -$15.15 million. In the same quarter last year, Contineum Therapeutics's earnings per share (EPS) was -$0.62.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.

When does Contineum Therapeutics report earnings?

The next CTNM earnings call is Oct 29, 2026. Add CTNM to your watchlist to be reminded of Contineum Therapeutics's next earnings date.

Is Contineum Therapeutics profitable or losing money?

As of the last Contineum Therapeutics earnings report, Contineum Therapeutics is currently losing money. Contineum Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$57.56 million, a 1.22% increase year over year.

What was CTNM's earnings growth in the past year?

As of Contineum Therapeutics's earnings date in Aug 4, 2026, Contineum Therapeutics's earnings has grown year over year. CTNM earnings in the past year totalled -$57.56 million.

What are Contineum Therapeutics's earnings expectations?

The current EPS estimate for Contineum Therapeutics's earnings report in Oct 29, 2026 is -$0.45.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.